BioInvest ApS: Financial statements 2022
CVR: 41998288
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioInvest ApS (CVR 41998288) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -12,500 and a net result of DKK -183,766,349 compared with DKK 284,250,983 the year before. Equity in the 2022 report amounted to DKK 203,784,704. The solvency ratio was 99.4%.
- Gross Profit
- DKK -12,500
- Profit/Loss
- DKK -183,766,349
- Equity
- DKK 203,784,704
- Total Assets
- DKK 205,038,536
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13 t. | -183.8 mio. | 203.8 mio. | 0 |
| 2021 | - | 0 | 284.3 mio. | 387.6 mio. | 0 |
| 2020 | - | -20 t. | 81.5 mio. | 103.3 mio. | 0 |
Official annual report
Keep an eye on BioInvest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioInvest ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 284,250,983.
About BioInvest ApS
BioInvest ApS was a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company has been dissolved on 9 November 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2022 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK -12,500 and a net result of DKK -183,766,349 compared with DKK 284,250,983 the year before. Equity in the 2022 report amounted to DKK 203,784,704.